According to OSE Immunotherapeutics's latest financial reports the company's current revenue (TTM ) is โฌ62.46 Million. In 2024 the company made a revenue of โฌ69.87 Million an increase over the revenue in the year 2023 that were of โฌ2.22 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.